Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD

Recruiting

Phase 2

Phase 3

NRCT-101SRStudy to Evaluate NRCT-101SR in Pediatric Subjects with ADHD

Sponsor:

Neurocentria, Inc.

Code:

NCT06215144

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Eligibility Criteria

Sex: All

Age: 13 - 17

Healthy Volunteers: Not accepted

Interventions

NRCT-101SR

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Neurocentria, Inc. on 2025-03-12.